Literature DB >> 6160841

Council Lecture. Drusen and their relationship to senile macular degeneration.

S H Sarks.   

Abstract

This study is based on the clinico-pathological examination of 512 eyes. As senile macular degeneration developed drusen appeared to alter in consistency and become more fluid. This resulted in a spectrum of clinical appearances classified as hard, semisolid, soft or serous, and regressing. Histologically the hyaline contents of the drusen changed to a pale-staining amorphous material which electron microscopy showed to consist of vesicles. This membranous debris first appeared beneath the pigment epithelium in normal aged eyes but its later accumulation led to a widespread shallow separation of the basement membrane. The softening of drusen was most evident in group IV in which subretinal neovascularization was first detected. At this stage the retinal pigment epithelium also showed its greatest proliferative activity and the formation of abnormal basement membrane material.

Entities:  

Mesh:

Year:  1980        PMID: 6160841     DOI: 10.1111/j.1442-9071.1980.tb01670.x

Source DB:  PubMed          Journal:  Aust J Ophthalmol        ISSN: 0310-1177


  49 in total

1.  Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study.

Authors:  S H Sarks; J J Arnold; M C Killingsworth; J P Sarks
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

2.  CNV subtype in first eyes predicts severity of ARM in fellow eyes.

Authors:  S Abugreen; K A Muldrew; M R Stevenson; R VanLeeuwen; P T V M DeJong; U Chakravarthy
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

3.  Prevalence of reticular pseudodrusen in age-related macular degeneration with newly diagnosed choroidal neovascularisation.

Authors:  S Y Cohen; L Dubois; R Tadayoni; C Delahaye-Mazza; C Debibie; G Quentel
Journal:  Br J Ophthalmol       Date:  2006-09-14       Impact factor: 4.638

4.  Senile macular degeneration: the involvement of immunocompetent cells.

Authors:  P L Penfold; M C Killingsworth; S H Sarks
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

5.  Histologic and Optical Coherence Tomographic Correlates in Drusenoid Pigment Epithelium Detachment in Age-Related Macular Degeneration.

Authors:  Chandrakumar Balaratnasingam; Jeffrey D Messinger; Kenneth R Sloan; Lawrence A Yannuzzi; K Bailey Freund; Christine A Curcio
Journal:  Ophthalmology       Date:  2017-01-30       Impact factor: 12.079

6.  Angiogenesis in early choroidal neovascularization secondary to age-related macular degeneration.

Authors:  M C Killingsworth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-06       Impact factor: 3.117

7.  Clinical experience with interferon alfa-2a for exudative age-related macular degeneration.

Authors:  J N Kirkpatrick; A D Dick; J V Forrester
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

8.  Treatment of choroidal neovascularisation in age-related macular degeneration with interferon alfa-2a and alfa-2b.

Authors:  M C Gillies; J P Sarks; P E Beaumont; A B Hunyor; D McKay; M Kearns; P J McClusky; S H Sarks
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

Review 9.  The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD.

Authors:  Sayantan Datta; Marisol Cano; Katayoon Ebrahimi; Lei Wang; James T Handa
Journal:  Prog Retin Eye Res       Date:  2017-03-20       Impact factor: 21.198

Review 10.  Symposium on age-related macular degeneration.

Authors:  L A Yannuzzi; R Friedman; S L Fine; J D Gass; K A Gitter; D H Orth; L J Singerman
Journal:  Bull N Y Acad Med       Date:  1988-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.